---
schema_version: "secwatch.filing_event.v1"
accession: "0001161697-22-000276"
form_type: "8-K"
ticker: "USBC"
cik: "0001074828"
company_name: "USBC, Inc."
filed_at: "2022-05-31T23:59:59+00:00"
generated_at: "2026-06-25T05:46:04.979115+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Know Labs appoints CFO Peter Conley and CPO Steven Kent to lead toward FDA clearance

## Summary
- Peter Conley appointed CFO and SVP Intellectual Property, with 34 years finance and IP experience.
- Steven Kent appointed Chief Product Officer, responsible for product development and clinical testing.
- Company progresses toward FDA clearance for non-invasive glucose monitor; executive team expanded.
- Leo Trautwein remains CMO; Masanori King Takee as SVP Software Engineering.

## SEC filing metadata
- accession: 0001161697-22-000276
- form_type: 8-K
- ticker: USBC
- cik: 0001074828
- company_name: USBC, Inc.
- filed_at: 2022-05-31T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1074828/000116169722000276/0001161697-22-000276-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1074828/000116169722000276/form_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001161697-22-000276
- JSON: https://secwatch.observer/filing/0001161697-22-000276.json
- Plain text: https://secwatch.observer/filing/0001161697-22-000276.txt

## Key facts
- Executive change
  Peter Conley was appointed as Chief Financial Officer and SVP Intellectual Property at USBC, Inc..
  - Action: appointed
  - Role: Chief Financial Officer and SVP Intellectual Property
  source text: Peter Conley, Chief Financial Officer and SVP Intellectual Property (IP) – Mr. Conley brings over 34 years of corporate finance and equity capital markets experience, more than $5B in equity transactions, and over 20 years of specialization in strategic IP analysis, IP development and IP monetization to Know Labs, joining the company as Chief Financial Officer and SVP, Intellectual Property.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1074828/000116169722000276/0001161697-22-000276-index.htm
- Executive change
  Steven Kent was appointed as Chief Product Officer at USBC, Inc..
  - Action: appointed
  - Role: Chief Product Officer
  source text: Steven Kent, Chief Product Officer – Mr. Kent joins Know Labs as Chief Product Officer, where he will be responsible for product development and clinical testing.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1074828/000116169722000276/0001161697-22-000276-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.